Andy Batts
Long only, value, growth, momentum

Syneron: Undervalued In A High Growth Industry

Syneron Medical (NASDAQ:ELOS) is an Israel-based company that manufactures and distributes medical aesthetic devices powered by its proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. In the last one year, the shares of Syneron have traded between a low of $7.21 and a high of $11.92. Given Syneron's leadership position in the aesthetic devices market and its recently announced joint venture with Unilever (NYSE:UL), I feel the stock is meaningfully undervalued at its current level.

The Business

Syneron is a global leader in aesthetic devices with 28% worldwide market share. The company's highly innovative ELOS (Electro-Optical Synergy) technology provides the foundation for effective, safe and cost-effective tools that help physicians offer long-lasting...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details